Carregando empresa
Just reported
Q3 2026 results
From Encompass Health's results release of 28 de outubro de 2026; its quarterly report has since been filed.
Revenue
Actual
US$ 1,61B
+8,9% y/y
+0,8% q/qGuided
—
No guide given
EPS, GAAP
Actual
US$ 1,50
+21% y/y
-2,6% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Encompass Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.US$ 22,8BA+
ENSGEnsign Group, Inc.US$ 10,9BA
PACSPACS Group, Inc.US$ 7,6BA
CONConcentra Group Holdings Parent, Inc.US$ 5,4BA
LFSTLifeStance Health Group, Inc.US$ 5,4BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 de out. de 2026CBGraded C, now B
MCKMckesson Corporation4 de nov. de 2026BAGraded B, now A
CVSCVS Health Corp4 de nov. de 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 de nov. de 2026BAGraded B, now A
BIIBBiogen Inc.28 de out. de 2026BAGraded B, now A
Demonstrações financeiras completas →
Construído a partir dos próprios documentos de Encompass Health Corporation entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
